Maternal serum soluble adhesion molecule levels at 11+0-13+6 weeks and subsequent development of pre-eclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 20, Issue 11, 2007, Pages 793-796

  Parra Cordero, Mauro ^a,b   Turan, Ozhan M ^a   Kaur, Andrea ^a   Pearson, Jeremy D ^c   Nicolaides, Kypros H ^a,d  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adhesion molecule; Pre eclampsia; Screening; Uterine artery Doppler

Indexed keywords

BIOCHEMICAL MARKER; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; GESTATION PERIOD; HUMAN; MATERNAL SERUM; PREDICTOR VARIABLE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; UTERINE ARTERY;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PULSATILE FLOW; ULTRASONOGRAPHY, PRENATAL; UTERUS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 35349013210     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050701500349     Document Type: Article

References (12)

1. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response - A review. Placenta 2003;17:S21-S27.
2. Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002;23:359-372.
3. Gearing A, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14:506-512.
4. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997;99:2139-2151.
5. Labarrere CA, Faulk WP. Intercellular adhesion molecules-1 (ICAM-1) and HLA-DR antigens are expressed on endovascular cytotrophoblast in abnormal pregnancies. Am J Reprod Immunol 1995;33:47-53.
6. Chaiworapongsa T, Romero R, Yoshimatsu J, Espinoza J, Kim YM, Park K, Kalache K, Edwin S, Bujold E, Gomez R. Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia. J Matern Fetal Neonatal Med 2002;12:19-27.
7. Krauss T, Kuhn W, Lakoma C, Augustin HG. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 1997;177:443-449.
8. Krauss T, Emons G, Kuhn W, Augustin HG. Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy. Clin Chem 2002;48:1418-1424.
9. Clausen T, Djurovic S, Brosstad FR, Berg K, Henriksen T. Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: Indicators of disturbed placentation in absence of evidence of endothelial dysfunction? Am J Obstet Gynecol 2000;182:321-325.
10. Higgins JR, Papayianni A, Brady HR, Darling MR, Walshe JJ. Circulating vascular cell adhesion molecule-1 in pre-eclampsia, gestational hypertension, and normal pregnancy: Evidence of selective dysregulation of vascular cell adhesion molecule-1 homeostasis in pre-eclampsia. Am J Obstet Gynecol 1998;179:464-469.
11. Papageorghiou AT, Yu CK, Erasmus IE, Cuckle HS, Nicolaides KH. Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler. BJOG 2005;112:703-709.
12. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblast to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997;99:2152-2164.